<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T02:35:11Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2099.1/16756" metadataPrefix="marc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2099.1/16756</identifier><datestamp>2025-07-23T06:54:10Z</datestamp><setSpec>com_2072_1033</setSpec><setSpec>col_2072_452951</setSpec></header><metadata><record xmlns="http://www.loc.gov/MARC21/slim" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
   <leader>00925njm 22002777a 4500</leader>
   <datafield ind2=" " ind1=" " tag="042">
      <subfield code="a">dc</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Humbert, Delphine</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="260">
      <subfield code="c">2012-02</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="520">
      <subfield code="a">Mobilitat-Incoming</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="520">
      <subfield code="a">Cardiovascular diseases are major concerns in public health of developed countries and the&#xd;
first cause of death in the world. The treatment of coronary artery diseases using metallic&#xd;
stents has been one of the most revolutionary and most rapidly adopted medical&#xd;
interventions of these last years. During early development much of the investigation and&#xd;
debate revolved around stent design, including assessment of different materials and surface&#xd;
treatments. However, restenosis, incomplete endothelialization, and thrombosis hamper the&#xd;
long term clinical success.&#xd;
The biological events that lead to the appropriate response of already successfully proved&#xd;
biomaterial surfaces, such as Co-Cr alloy for cardiovascular stents, are mainly influenced by&#xd;
the interactions at the bio/non-bio interface. To improve the endothelial cells adhesion and&#xd;
growth, surface treatments have been developed to anchor REDV elastin-like polymers&#xd;
which enhances surface endothelization . The aim of the present project is to obtain a new&#xd;
family of biofunctionalized Co‐Cr alloy surface by covalently-anchoring the REDV elastin-like&#xd;
polymer.&#xd;
Different surface treatments have been performed on CoCr: O2 plasma treatment,&#xd;
silanization with CPTES and NaOH basic etching previously to chemically or physically&#xd;
attach the biopolymer. Then surface characterization has been performed, for each step, in&#xd;
termsof surface wettability, roughness, topography, chemistry, and charge. A biochemist&#xd;
characterization has been done to quantify the adsorbed biopolymer by means of fluorescent&#xd;
assays to evaluate the efficiency of the surface treatments.&#xd;
CoCr alloy surfaces were successfully biofunctionalized with REDV elastin–like polymer. The&#xd;
quantity of adsorbed biopolymer was influenced by surface characteristics. All surfaces&#xd;
revealed considerable quantities of attached biopolymer, but combination of NaOH+CPTES&#xd;
series attached the highest amount (0,008 μg/mm2± 0,002) compared to NaOH series (0,005&#xd;
μg/mm2± 0,003), CPTES series (0,004 μg/mm2± 0,001), control samples (0,003 μg/mm2±&#xd;
0,001) and O2 plasma series (0,002 μg/mm2± 0, 0005). The quantity of hydroxiles formed on&#xd;
the different surfaces influences biopolymer adsorption and then, cell response.</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Àrees temàtiques de la UPC::Enginyeria biomèdica::Biomaterials</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Chromium-copper alloys -- Therapeutic use</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Biomaterials</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Cardiovascular system – Diseases</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Aliatges de coure i crom -- Ús terapèutic</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Biomaterials</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Sistema cardiovascular – Malalties</subfield>
   </datafield>
   <datafield ind2="0" ind1="0" tag="245">
      <subfield code="a">Funcionalización de superficies de CoCr para aplicaciones cardiovasculares</subfield>
   </datafield>
   <datafield ind2="0" ind1="0" tag="245">
      <subfield code="a">Functionalization of CoCr surfaces for cardiovascular applications</subfield>
   </datafield>
</record></metadata></record></GetRecord></OAI-PMH>